Regina Dodis is an Endocrinology/Metabolic physician affiliated with Launchpad Central. OpenAlex indexes 6 publications with 344 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1006 Wh Smith Blvd
Greenville, NC 278345194
Telephone
252-413-6683Registry record last updated 29 Jun 2015.
Industry payments
43 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Sequel Med Tech, LLCProgram year20252 payments
- Ascendis Pharma Endocrinology IncProgram year20255 payments
- Bayer Healthcare Pharmaceuticals Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
49.6%RANK Ligand Inhibitor49.5%Denosumab100%Prolia0%Part D + Part B<11 patientsgamma-Aminobutyric Acid-ergic Agonist0.1%Baclofen100%Part D<11 patientsMetabolism & gastrointestinal
27.5%Insulin Analog10.3%Novolog Flexpen12%Tresiba Flextouch U-10011%Toujeo Solostar10%Humalog Kwikpen U-1009%Lantus Solostar9%Tresiba Flextouch U-2006%Toujeo Max Solostar6%Novolog6%Fiasp Flextouch5%Humalog5%Insulin Lispro Kwikpen U-1004%Insulin Lispro4%Fiasp3%Lyumjev3%Basaglar Kwikpen U-1003%Insulin Aspart Flexpen3%Lyumjev Kwikpen U-1002%Humalog Kwikpen U-2002%Part D<11 patientsGLP-1 receptor agonist5.6%Ozempic69%Trulicity12%Mounjaro12%Rybelsus7%Part D<11 patients+ 13 more classes in this area
Hormonal (systemic)
12%l-Thyroxine8.7%Levothyroxine Sodium71%Synthroid28%Euthyrox2%Part D<11 patientsThyroid Hormone Synthesis Inhibitor2.1%Methimazole100%Part D≥51 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Atul Chugh, MD
Launchpad Central
Valerie Arnold, MD
Launchpad Central
Yogesh Paliwal, MD
Launchpad Central
Pascal Dabel, MD
Launchpad Central
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”